US-based pharmacy Caligor Rx has taken over clinical trial material management services provider The Coghlan Group for an undisclosed sum.

Caligor delivers comparator drugs, rescue medications, combination therapies, ancillary supplies, and logistical support for clinical trials.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Caligor expects the acquisition to enable it to develop clinical trial secondary packaging and labelling capabilities globally.

“Zhejiang Jolly Pharmaceutical has reached an agreement to divest 85% stake in a pharmaceutical company for CNY21.1m ($3.18m).”

Zhejiang Jolly Pharmaceutical has reached an agreement to divest 85% stake in a pharmaceutical company for CNY21.1m ($3.18m).

Based in China, Zhejiang Jolly is involved in research, development, manufacturing and sales of medicinal fungi series products.

The transaction will reduce the divesting company’s stake to 15%.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Pharmaceutical Technology Excellence Awards - The Benefits of Entering

Gain the recognition you deserve! The Pharmaceutical Technology Excellence Awards celebrate innovation, leadership, and impact. By entering, you showcase your achievements, elevate your industry profile, and position yourself among top leaders driving pharmaceutical advancements. Don’t miss your chance to stand out—submit your entry today!

Nominate Now